“bob-nelsen” Archives

in
Entry Author Date Location
Illumina CEO Flatley To Step Aside, deSouza To Take Reins in July 03/07/16 San Diego
Unity Bio Wants To “Lengthen Health Span,” But 1st Goals More Modest 02/03/16 San Francisco
Big Name VCs Back Seattle ‘Startup Studio’ Pioneer Square Labs 10/01/15 Seattle
With New CEO, Seattle’s Faraday Pharma Aims to Exploit Ikaria Roots 09/03/15 Seattle
With $36M Funding, Arivale Walks Line To Push Wellness Business 07/14/15 Seattle
Denali Rises With $217M and Genentech Alumni to Fight Brain Diseases 05/14/15 San Francisco
Slideshow: Seattle Biotech Seizes the Momentum 05/07/15 Seattle
Here’s The Agenda for Seattle Biotech Seizes The Momentum, May 6 04/20/15 Seattle
Join Us May 6 at the Hutch to Discuss Seattle Biotech’s Wild Ride 04/14/15 Seattle
West Coast Biotech Roundup: Amgen/deCODE, Calico, Orexigen & More 03/27/15 San Diego
Seattle’s Gilliland, Nelsen, Hood, Franklin & More to Gather May 6 03/26/15 Seattle
Juno Just Raised A Ton of Cash. Here Comes the Spending Part. 12/19/14 Seattle
More Biotechs Belly-Up These Days but Dendreon Still “One of a Kind” 12/02/14 National
Juno, Less Than a Year Old, Lines up IPO to Fund Cancer Work 11/17/14 Seattle
Syros Raises $53M More To Push Gene-Control Drugs Into Human Trials 10/27/14 Boston
West Coast Biotech Roundup: ARCH, Ebola, ViaCyte, Calithera & More 08/28/14 San Francisco
ARCH Venture Exploits IPO Window To Raise $400M Fund, Its Eighth 08/27/14 Seattle
With $310M and Public Investors Aboard, Is a Juno IPO Next? 08/05/14 Seattle
Amid Court Fight and Trial Pauses, Juno Closes First Round at $176M 04/24/14 Seattle
Juno Therapeutics Grabs $120M to Coax Immune System to Fight Cancer 12/03/13 Seattle
Celgene Emerges as Biotech’s Shrewdest, Nimblest Dealmaker 08/05/13 National
How to Make the Payers Pay: Join the Xconomy Event April 9 03/26/13 Seattle
Biotech for the Belt-Tightening Era: Last Chance For Early-Bird Tix 03/12/13 Seattle
Who Will Survive the Biotech VC Downturn? The Young and the Proven 10/22/12 National
Exclusive: OVP Venture Partners, NW’s Oldest VC Firm, To Shut Down 10/11/12 Seattle
Biotech IPOs Start to Show Some Modest Signs of Life 04/30/12 National
Merck Returns to SD, Pouring $90M Into New Schultz-Led Institute 03/15/12 San Diego
Amgen Mulls R&D Cuts, Thong Le Named WBBA Chairman, NanoString’s Version 2.0, & More Seattle-Area Life Sciences News 10/13/11 Seattle
Pfizer, deCode Genetics Strike Deal To Look For New Lupus Drug Targets 10/12/11 New York
Dendreon Slashes 500 Jobs, Gates Foundation Adds Novartis Exec, Theraclone Tacks on $10M, & More Seattle-Area Life Sciences News 09/15/11 Seattle
Page 1 of 3 next page »